Table 8.
Authors | Carnitine Dosage | N1 | N2 | Mean 1 | SD 1 | Mean 2 | SD 2 | SMD | SE | 95% CI | t | p | Weight (%) | Test for Heterogeneity | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fixed | Random | Q | 72.6140 | ||||||||||||||
Arenas 1991 runner |
1 g/d, 3 w | 13 | 13 | 40.0 | 3 | 38.0 | 5 | 0.470 | 0.385 | −0.326 to 1.265 | 15.50 | 9.84 | DF | 10 | |||
Arenas 1991 sprinter | 2 g/d, 3 w | 11 | 11 | 34.0 | 4 | 36.0 | 3 | −0.544 | 0.418 | −1.417 to 0.328 | 13.16 | 9.70 | I2 (inconsistency) | 86.23% | |||
Arenas 1994 | 2 g/d, 4 w | 7 | 7 | 27.8 | 3.5 | 31.7 | 2.9 | −1.136 | 0.544 | −2.322 to 0.0504 | 7.77 | 9.08 | 95% CI for I2 | 77.18 to 91.69 | |||
Colombani 1996 | 4 g/d, 1 d | 7 | 7 | 41.5 | 2.9 | 45.8 | 2.0 | −1.616 | 0.586 | −2.893 to −0.339 | 6.70 | 8.86 | |||||
Cooper 1986 | 4 g/d, 10 d | 10 | 10 | 35.4 | 8.9 | 33.1 | 7.9 | 0.262 | 0.430 | −0.642 to 1.166 | 12.44 | 9.64 | |||||
Gorostiag 1989 | 2 g/d, 4 w | 10 | 10 | 31.4 | 1.7 | 39.2 | 3.3 | −2.846 | 0.621 | −4.151 to −1.541 | 5.97 | 8.67 | |||||
Marconi 1985 | 4 g/d, 2 w | 6 | 6 | 48.0 | 8.3 | 56.8 | 9.6 | −0.905 | 0.564 | −2.161 to 0.351 | 7.24 | 8.98 | |||||
Muller 2002 | 3 g/d, 10 d | 10 | 10 | 41.10 | 6.54 | 52.74 | 9.23 | −1.394 | 0.482 | −2.405 to −0.382 | 9.92 | 9.40 | |||||
Oyono-Enguelle 1989 | 2 g/d, 3 w | 10 | 10 | 49.8 | 2.3 | 59.4 | 3.9 | −2.872 | 0.624 | −4.183 to −1.560 | 5.91 | 8.66 | |||||
Oyono-Enguelle 1989 | 2 g/d, 4 w | 10 | 10 | 49.8 | 2.3 | 64.1 | 3.7 | −4.445 | 0.823 | −6.175 to −2.716 | 3.40 | 7.57 | |||||
Oyono-Enguelle 1989 | 2 g/d, 12 w | 10 | 10 | 49.8 | 2.3 | 48.0 | 3.5 | 0.582 | 0.438 | −0.338 to 1.502 | 12.00 | 9.61 | |||||
Total fixed effects | 104 | 104 | −0.787 | 0.152 | −1.086 to −0.488 | −5.189 | <0.001 | 100.00 | 100.00 | ||||||||
Total random effects | 104 | 104 | −1.216 | 0.416 | −2.036 to −0.395 | −2.921 | 0.004 | 100.00 | 100.00 | ||||||||
Authors | Carn. Dosage | Training | N1 | N2 | Mean 1 | SD 1 | Mean 2 | SD 2 | SMD | SE | 95% CI | t | p | Weight (%) | Test for Heterogeneity | ||
Fixed | Random | Q | 24.4106 | ||||||||||||||
DF | 6 | ||||||||||||||||
Arenas 1991 runner | 1 g/d, 3 w | After running | 13 | 13 | 22.9 | 1.8 | 25.7 | 2.6 | SMD | SE | 95% CI | Weight (%) | SMD | Significance level | p = 0.0004 | ||
Arenas 1991 sprinter | 2 g/d, 3 w | After running | 11 | 11 | 18.2 | 1.5 | 21.0 | 1.7 | −1.680 | 0.482 | −2.686 to −0.675 | Fixed | 10.38 | I2 (inconsistency) | 75.42% | ||
Colombani1996 | 4 g/d, 1 d | After running | 7 | 7 | 45.8 | 2.0 | 70.0 | 4.9 | −1.213 | 0.415 | −2.070 to −0.355 | 20.37 | −1.213 | 95% CI for I2 | 48.00 to 88.38 | ||
Cooper 1986 | 4 g/d, 10 d | After 158′ of Marathon | 10 | 10 | 22.5 | 2.8 | 35.0 | 12.6 | −1.680 | 0.482 | −2.686 to −0.675 | 15.13 | −1.680 | ||||
Gorostiaga1989 | 2 g/d, 4 w | After 40′ of exercise | 10 | 10 | 35.5 | 4.4 | 38.9 | 2.8 | −6.052 | 1.248 | −8.772 to −3.332 | 2.26 | −6.052 | ||||
Marconi 1985 | 4 g/d, 2 w | After 120′ of treadmill | 6 | 6 | 56.8 | 9.6 | 62.5 | 11.6 | −1.312 | 0.476 | −2.311 to −0.312 | 15.52 | −1.312 | ||||
Nuesch 1999 | 1 g/d | 10′ after maximal treadmill | 9 | 9 | 71.3 | 10.2 | 71.8 | 10.7 | −0.883 | 0.450 | −1.829 to 0.0635 | 17.32 | −0.883 | ||||
Total (fixed effects) | 66 | 66 | −0.494 | 0.542 | −1.702 to 0.714 | −5.660 | <0.001 | 11.96 | −0.494 | ||||||||
Total (random effects) | 66 | 66 | −0.0455 | 0.449 | −0.997 to 0.906 | −3.253 | 0.001 | 17.44 | −0.0455 | ||||||||
Authors | Carnitine Dosage | N1 | N2 | Mean 1 | SD 1 | Mean 2 | SD 2 | SMD | SE | 95% CI | t | p | Weight (%) | Test for Heterogeneity | |||
Fixed | Random | ||||||||||||||||
Arenas 1991 sprinter | 2 g/d, 3 w | 11 | 11 | 34.0 | 4 | 36.0 | 3 | −0.544 | 0.418 | −1.417 to 0.328 | 69.01 | 51.98 | Q | 9.5950 | |||
Oyono-Enguelle 1989 | 2 g/d, 3 w | 10 | 10 | 49.8 | 2.3 | 59.4 | 3.9 | −2.872 | 0.624 | −4.183 to −1.560 | 30.99 | 48.02 | DF | 1 | |||
Total fixed effects | 21 | 21 | −1.266 | 0.347 | −1.968 to −0.563 | −3.642 | 0.001 | 100.00 | 100.00 | Significance level | p = 0.0020 | ||||||
Total random effects | 21 | 21 | −1.662 | 1.163 | −4.012 to 0.688 | −1.429 | 0.161 | 100.00 | 100.00 | I2 | 89.58% | ||||||
95% CI for I2 | 61.34 to 97.19 | ||||||||||||||||
Arenas 1994 | 2 g/d, 4 w | 7 | 7 | 27.8 | 3.5 | 31.7 | 2.9 | −0.959 | 0.631 | −2.413 to 0.495 | 41.10 | 41.10 | Q | 0.03256 | |||
Gorostiaga 1989 | 2 g/d, 4 w | 10 | 10 | 31.4 | 1.7 | 39.2 | 3.3 | −0.888 | 0.785 | −2.664 to 0.888 | 26.51 | 26.51 | DF | 2 | |||
Oyono-Enguelle 1989 | 2 g/d, 4 w | 10 | 10 | 49.8 | 2.3 | 64.1 | 3.7 | −1.075 | 0.710 | −2.657 to 0.508 | 32.39 | 32.39 | Significance level | p = 0.9839 | |||
Total fixed effects | 27 | 27 | −0.978 | 0.404 | −1.801 to −0.154 | −2.418 | 0.021 | 100.00 | 100.00 | I2 | 0.00% | ||||||
Total random effects | 27 | 27 | −0.978 | 0.404 | −1.801 to −0.154 | −2.418 | 0.021 | 100.00 | 100.00 | 95% CI for I2 | 0.00 to 0.00 |
W: Weeks, g: grams, d: days, l: milliliter, min: minutes, L-carnitine L-carn, SD: standard deviation, N: number of subjects, 1: subjects that did not use carn., 2: subjects used carn, SMD: standard mean differences, SE: standard error, CI: confidential intervals.